A61603-induced contractions of the porcine meningeal artery are mediated by alpha1- and alpha2-adrenoceptors

Basic & Clinical Pharmacology & Toxicology
Suneet MehrotraAntoinette Maassen VandenBrink


It has recently been shown that A61603 (N-[5-(4,5-dihydro-1H-imidazol-2yl)-2-hydroxy-5,6,7,8-tetrahydro-naphthalen-1-yl]methane sulphonamide), a potent alpha(1A)-adrenoceptor agonist, decreased carotid artery conductance in anaesthetized pigs by a novel non-adrenergic mechanism. In this study, we set out to pharmacologically characterize A61603-induced contractions of the porcine isolated meningeal artery. While the maximum contractile responses of the artery were similar, A61603 (E(max): 183 +/- 23% of 100 mM KCl; pEC(50): 7.25 +/- 0.18) was more potent than noradrenaline (E(max): 156 +/- 16%; pEC(50): 5.75 +/- 0.17) or phenylephrine (E(max): 163 +/- 20%; pEC(50): 5.63 +/- 0.02). Prazosin (pA(2): 9.36 +/- 0.23) and, to a lesser extent, rauwolscine (pK(b): 6.36 +/- 0.38) and yohimbine (pK(b): 7.30 +/- 0.15) antagonised the contractions to A61603. The 5-HT(1B) (GR127935; N-[4-methoxy-3-(4-methyl-1-piperazinyl) phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide) and 5-HT(2) (ritanserin) receptor antagonists failed to affect the responses to A61603, but methiothepin, which, in addition, has a high affinity for alpha-adrenoceptors, proved an effective antagonist. The A61603-induced responses were suppr...Continue Reading


Nov 15, 1990·Biochemical and Biophysical Research Communications·J M HerbertJ P Maffrand
Oct 1, 1989·Medicinal Research Reviews·J C McGrathV G Wilson
Jan 1, 1987·Pharmacology & Toxicology·T SjöbergK E Andersson
Dec 1, 1987·Pflügers Archiv : European journal of physiology·N C NyborgM J Mulvany
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·K B SeamonJ W Daly
Sep 26, 1997·Naunyn-Schmiedeberg's Archives of Pharmacology·G W PriceD N Middlemiss
Jul 17, 1998·Circulation·A MaassenVanDenBrinkP R Saxena
Aug 12, 1999·European Journal of Pharmacology·H Zhong, K P Minneman
Dec 22, 1999·Naunyn-Schmiedeberg's Archives of Pharmacology·K I RoonP R Saxena
Dec 28, 1999·Brain : a Journal of Neurology·P Tfelt-HansenP J Goadsby
Apr 5, 2003·Drug News & Perspectives·Edwin W. WillemsPramod R. Saxena
Apr 29, 2003·Cephalalgia : an International Journal of Headache·E W WillemsP R Saxena
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Jan 28, 2004·European Journal of Pharmacology·Carlos M VillalónLuis F Valdivia
May 12, 2006·Cephalalgia : an International Journal of Headache·U ArulmaniP R Saxena
Nov 15, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Suneet MehrotraAntoinette Maassenvandenbrink

❮ Previous
Next ❯


May 16, 2008·American Journal of Physiology. Renal Physiology·Minoru MiyazatoNaoki Yoshimura
May 9, 2012·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Angélica Barrera-GarcíaTania Zenteno-Savín
Apr 27, 2016·Analytica Chimica Acta·Nawel Mejri-OmraniHafsa Korri-Youssoufi
Jun 4, 2015·The Veterinary Clinics of North America. Equine Practice·Ahmad Al-Dissi
Aug 9, 2016·Journal of Ethnopharmacology·Suman BiswasTapan Kumar Mandal
Aug 20, 2020·Cephalalgia : an International Journal of Headache·Bianca N MasonAndrew F Russo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.